Neuroone Medical Technologies (NMTC) Non-Current Debt (2010 - 2019)

Neuroone Medical Technologies (NMTC) posted Non-Current Debt of $528000.0 for Q3 2019, little changed on a QoQ basis from $528000.0 in Q2 2019.

Neuroone Medical Technologies (NMTC) Non-Current Debt (2010 - 2019) Analysis & Trends

Neuroone Medical Technologies' Non-Current Debt history runs 5 years deep, the most recent figure standing at $528000.0 for Q3 2019.

  • Quarterly Non-Current Debt changed N/A year-over-year to $528000.0 in Q3 2019, while the trailing twelve-month figure through Sep 2019 was $528000.0 (changed N/A YoY) and the FY2019 annual result came in at $528000.0, changed N/A from the prior year.
  • Non-Current Debt was $528000.0 for Q3 2019 at Neuroone Medical Technologies, roughly flat from $528000.0 in the prior quarter.
  • Across five years, Non-Current Debt topped out at $528000.0 in Q4 2018 and bottomed at $283000.0 in Q2 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 29.64 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 14.22 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 26.17 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 10.99 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 598.50 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 8.07 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 10.13 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn - 3.18 Bn
10 Neuroone Medical Technologies 7.99 Mn 5.19 Mn 990,264.00 -

Historic Data

Download Data
DateValue
Sep 30, 2019 528,000.00
Jun 30, 2019 528,000.00
Mar 31, 2019 528,000.00
Dec 31, 2018 528,000.00
Jun 30, 2018 283,000.00
Dec 31, 2012 17,000.00
Sep 30, 2012 12,500.00
Jun 30, 2012 12,500.00
Mar 31, 2012 12,500.00
Dec 31, 2011 12,500.00
Sep 30, 2011 16,000.00
Jun 30, 2011 16,000.00
Dec 31, 2010 10,500.00
Sep 30, 2010 10,500.00